TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Skandinavisk BioTech AB
Closing information (x1000 SEK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
5,978
|
6,085 | |
| Financial expenses |
3
|
1 | |
| Earnings before taxes |
821
|
966 | |
| EBITDA |
718
|
956 | |
| Total assets |
9,614
|
8,774 | |
| Current assets |
7,156
|
6,556 | |
| Current liabilities |
1,004
|
905 | |
| Equity capital |
7,940
|
7,296 | |
| - share capital |
100
|
100 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
82.6%
|
83.2% | |
| Turnover per employee |
5,978
|
6,085 | |
| Profit as a percentage of turnover |
13.7%
|
15.9% | |
| Return on assets (ROA) |
8.6%
|
11.0% | |
| Current ratio |
712.7%
|
724.4% | |
| Return on equity (ROE) |
10.3%
|
13.2% | |
| Change turnover |
-107
|
2,069 | |
| Change turnover % |
-2%
|
-2%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.